>
LIVE ELECTION RESULTS: New York mayor, NJ & VA governor, Prop 50, Trump endorsements, latest vote
Sen. Markwayne Mullin Reveals Schumer Held Secret BACKROOM MEETING...
RIP NYC - Muslim Communist Zohran Mamdani Wins New York City Mayoral Race
Dramatic Footage Shows UPS Cargo Jet Crashing At Louisville Airport
Japan just injected artificial blood into a human. No blood type needed. No refrigeration.
The 6 Best LLM Tools To Run Models Locally
Testing My First Sodium-Ion Solar Battery
A man once paralyzed from the waist down now stands on his own, not with machines or wires,...
Review: Thumb-sized thermal camera turns your phone into a smart tool
Army To Bring Nuclear Microreactors To Its Bases By 2028
Nissan Says It's On Track For Solid-State Batteries That Double EV Range By 2028
Carbon based computers that run on iron
Russia flies strategic cruise missile propelled by a nuclear engine
100% Free AC & Heat from SOLAR! Airspool Mini Split AC from Santan Solar | Unboxing & Install

Scientists at University College London (UCL) have demonstrated in rodents a new type of "micromagnet" that can work as a miniaturized mechanical switch to turn on touch-sensitive cells, offering a new method for controlling specific regions of the brain.
There are parallels between this breakthrough and another exciting branch of research focused on careful control of cells in the body, known as optogenetics. This technique involves inserting genes into otherwise regular calls to make them sensitive to light, allowing them to be stimulated for the purposes of treating paralysis, relieving pain and restoring vision.
Although there have been success stories, such as a case when optogenetics was used for partial vision restoration in a human for the first time last year, adapting the technology for clinical use has proven difficult due to the need for genetic modification of the cells. The UCL team has come up with another way of controlling brain activity that doesn't involve such measures.
"Our new technology uses magnetic particles and magnets to remotely and precisely control brain cell activity and, importantly, does this without introducing any device or foreign gene into the brain," said lead researcher Dr Yichao Yu.
The team's magnet-centric approach involves targeting brain cells called astrocytes, which live between the brain's blood vessels and nerve cells and supply neurons with metabolic and structural support, while also regulating activity of neuronal circuits. Conveniently for the scientists, they also happen to be touch-sensitive.
"Because astrocytes are sensitive to touch, decorating them with magnetic particles means you can give the cells a tiny prod from outside the body using a magnet, and as such, control their function," said senior author, Professor Mark Lythgoe. "This ability to remotely control astrocytes provides a new tool for understanding their function and may have the potential to treat brain and mood disorders, including depression."